Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Dec 2024 value amounting to $736,339.

  • Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) rose 1323.84% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 1323.84%. This contributed to the annual value of $736,339 for FY2024, which is 9191.34% up from last year.
  • As of FY2024, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) stood at $736,339, which was up 9,191.34% from $7,925 recorded in FY2023.
  • Tonix Pharmaceuticals Holding's 5-year Shares Outstanding (Diluted Average) high stood at $736,339 for FY2024, and its period low was $7,925 during FY2023.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's median Shares Outstanding (Diluted Average) value was $372,132 (recorded in 2023), while the average stood at $372,132.
  • Data for Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) shows a peak YoY surged of 9,191.34% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) stood at $7,925 in 2023, then soared by 9,191.34% to $736,339 in 2024.